pyrazolanthrone has been researched along with afimoxifene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faller, DV; Wang, S; Zhang, B | 1 |
1 other study(ies) available for pyrazolanthrone and afimoxifene
Article | Year |
---|---|
BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists.
Topics: Anthracenes; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatin; Chromatin Immunoprecipitation; DNA Helicases; Enzyme Inhibitors; Estrogen Antagonists; Female; Flow Cytometry; G1 Phase; Gene Expression Regulation; Humans; Immunoblotting; Luciferases; Mitogen-Activated Protein Kinase 8; Nuclear Proteins; Precipitin Tests; Prohibitins; Receptors, Estrogen; Repressor Proteins; RNA, Small Interfering; Tamoxifen; Transcription Factors | 2004 |